Ramona Montironi

Dr. Ramona Montironi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2024 in Biology
Verified
Journal Article
Open access
PDF file
SGStefano Raffaele Giannubilo
Stefano Raffaele Giannubilo
Daniela MarzioniDaniela Marzioni
Daniela Marzioni
Giovanni TossettaGiovanni Tossetta
Giovanni Tossetta
RMRamona Montironi
Ramona Montironi
MMMaria Liberata Meccariello
Maria Liberata Meccariello
ACAndrea Ciavattini
Andrea Ciavattini
Pregnancy is generally studied as a biological interaction between a mother and a fetus; however, the father, with his characteristics, lifestyle, genetics, and living environment, is by no means unrelated to the outcome of pregnancy. The half of the fetal genetic heritage of paternal derivation can be decisive in cases of inherited chromosomal disorders, and can be the result of de novo genetic alterations. In addition to the strictly pathological aspects, paternal genetics may transmit thrombophilic traits that affect the implantation and vascular construction of the feto-placental unit, lead to placenta-mediated diseases such as pre-eclampsia and fetal growth retardation, and contribute to the multifactorial genesis of preterm delivery. Biological aspects of immunological tolerance to paternal antigens also appear to be crucial for these pathologies. Finally, this review describes the biological findings by which the environment, exposure to pathogens, lifestyle, and nutritional style of the father affect fetal pathophysiological and epigenetic definition.

Verified
Journal Article
Open access
PDF file
RMRamona Montironi
Ramona Montironi
VTvalentina tosto
valentina tosto
DQDayana Quintili
Dayana Quintili
DCDaniele Crescenzi
Daniele Crescenzi
GBGiovanna Irene Battistoni
Giovanna Irene Battistoni
ACAndrea Ciavattini
Andrea Ciavattini
Fetal intestinal volvulus is a rare condition that can lead to hemorrhage, bowel necrosis, and urgent surgical treatment after birth. Thus, prompt diagnosis and treatment are essential to avoiding fetal or neonatal demise. Prenatal ultrasound is a keystone tool in the diagnostic course. However, sonographic findings tend to be non-specific, with limited understanding of the pathophysiology behind their atypical presentation. With a literature review and a case series, we aim to optimize the antenatal diagnosis and management of this rare but life-threatening condition. Six cases from our institution were retrospectively analyzed over 12 years. A literature review was conducted until December 2022. A total of 300 articles matched the keyword “Fetal volvulus”, and 52 studies were eligible for the review. Our 6 cases are added to the 107 cases reported in the literature of fetal intestinal volvulus with antenatal ultrasound assessment and without associated gastroschisis or omphalocele. Several prenatal symptoms and ultrasound markers, even if not specific, were more frequently reported. Different experiences of management were described regarding follow-up, the timing of delivery, the mode of delivery, and surgery outcomes. This paper highlights the importance of suspecting and assessing fetal volvulus at routine ultrasound scans, describing the most frequent antenatal presentations and management in order to improve fetal and neonatal outcomes.

Verified
Journal Article
Open access
PDF file
RMRamona Montironi
Ramona Montironi
SGStefano Raffaele Giannubilo
Stefano Raffaele Giannubilo
ICIrene Cappanera
Irene Cappanera
GCGiulia Capogrosso
Giulia Capogrosso
RMRomina Mancinelli Mancinelli
Romina Mancinelli Mancinelli
ACAndrea Ciavattini
Andrea Ciavattini
The introduction of cystic fibrosis transmembrane conductance regulator modulators (CFTRms) in the treatment of cystic fibrosis (CF) has significantly improved both the life expectancy and quality of life for patients affected by the disease. While this new therapy shows promising results in CF patients, data about the use of CFTRms during pregnancy in women who are carriers with fetuses affected by CF are limited. We present a new case report and literature review of fetal CF treated by the maternal assumption of CFTRms to understand the safety and the effectiveness of the treatment in resolving fetal and neonatal CF clinical manifestations (meconium ileus, postnatal exocrine pancreatic insufficiency, and postnatal intestinal surgery). Our report represents the fifth unsuccessful case of fetal CF treated in utero by CFTRms and highlights the potential key elements necessary for a successful treatment.